SYNERGY - Bone Grafting Material. Vial 4,0 cc Cancelous Bovine Xenograft granules. Small particle size 350-840 micron. Vial 4,0 cc. - # HU2G-840

SYNERGY  - Bone Grafting Material. Vial 4,0 cc  Cancelous Bovine Xenograft granules. Small particle size 350-840 micron. Vial 4,0 cc. - # HU2G-840
SYNERGY  - Bone Grafting Material. Vial 4,0 cc  Cancelous Bovine Xenograft granules. Small particle size 350-840 micron. Vial 4,0 cc. - # HU2G-840 SYNERGY  - Bone Grafting Material. Vial 4,0 cc  Cancelous Bovine Xenograft granules. Small particle size 350-840 micron. Vial 4,0 cc. - # HU2G-840 SYNERGY  - Bone Grafting Material. Vial 4,0 cc  Cancelous Bovine Xenograft granules. Small particle size 350-840 micron. Vial 4,0 cc. - # HU2G-840
SKU: 483612 - Ordered from Manufacturer - ETD 6-7 DAYS
$144.90
$124.00
You save: $20.90 ( 14% )
Quantity:

Minimum quantity is 1.

Manufacturer #
HU2G-840
Manufacturer
Model
SYNERGY
SubModel
Xenograft
Style
Cancellous
Sizes
4,0 cc
Features
Resolvable
Features
Bone
Features
Mineralized
Package
1pk
Diameter
350-840 micron
ETD
6-7 DAYS

Earn up to 130 rewards points with this product!

Join today and start earning rewards points and unlock exclusive savings with US Dental Depot's Customer Loyalty Rewards Program

SmileRewards Club

Description

SYNERGY
Regenerative Solutions

Bone grafting Mat. HU2G-840

Reference HU2G-840 · SYNERGY Xenograft / Bone substitute · Regenerative graft material
Bone Grafting Mat. HU2G-840 — product photo

DESCRIPTION

SYNERGY Bone grafting material, reference HU2G-840, Bone grafting Mat. HU2G-840. A Xenograft / processed Bone substitute used in guided Bone regeneration (GBR), socket preservation, sinus floor augmentation, and ridge augmentation procedures.

The material provides an osteoconductive scaffold that supports new Bone formation across the defect during the integration period.

Reference: HU2G-840 · Bone grafting Mat. HU2G-840.
Function: osteoconductive scaffold for guided Bone regeneration.
Format: granular / particulate (per the size designation — 840 or 2000 µm range).
Source: processed Xenograft / Bone substitute (lyophilized).
Indication: socket preservation, ridge augmentation, sinus elevation, peri-implant defects.
Use protocol: hydrate per IFU, combine with patient's blood / serum if specified by the IFU, place into the defect, cover with a barrier membrane as indicated.

CLINICAL APPLICATION

Used in regenerative procedures associated with implant dentistry — including extraction-socket preservation prior to delayed placement, ridge augmentation prior to or simultaneous with implant placement, lateral or transcrestal sinus floor elevation, and treatment of peri-implant osseous defects. The choice of granule size (840 µm vs 2000 µm range) is determined by the practitioner based on defect size and morphology.

Indication: GBR, socket preservation, ridge augmentation, sinus elevation.
Use barrier membrane (collagen or pericardium) per the case plan.
Hydrate the material per IFU before placement.
Achieve primary wound closure where possible to optimize graft outcomes.
Healing period: typically 4–9 months depending on defect, anatomy and protocol.

PLATFORM & COMPATIBILITY

Compatible with conventional GBR workflows. Often paired with a barrier membrane (collagen or Bovine pericardium) and primary closure to optimize regenerative outcomes. Consult the SYNERGY clinical literature and the practitioner's clinical judgement for case-specific protocols.

TECHNICAL SPECIFICATIONS

Manufacturer referenceHU2G-840
BrandSYNERGY
Product familyBone grafting Material
DesignationBone grafting Mat. HU2G-840
FormatGranular / particulate (per size designation in name)
OriginProcessed Xenograft / Bone substitute
IndicationGBR, socket preservation, ridge augmentation, sinus elevation
Package1pk
RegulatoryCE marking · ISO 13485 medical-device QMS

MATERIALS & SURFACE

Manufactured under controlled biological processing conditions designed to preserve the natural collagen structure and mineral matrix of the source tissue. Lot-controlled production with full traceability from raw material origin through final packaging.

Supplied terminally sterilized using validated methods appropriate to the biological substrate.

STERILIZATION & HANDLING

Supplied sterile, single-use, in primary and secondary protective packaging. Do not re-sterilize. Use only if the sterile barrier is intact at the time of opening. Storage at room temperature, away from direct sunlight and moisture; observe the printed expiration date.

Discard unused product after the procedure per local biohazard regulations. Verify lot number and expiration date prior to clinical use.

QUALITY ASSURANCE

Manufactured under ISO 13485 medical-device quality management and supplied with CE marking for the European market. Each lot is documented with origin traceability, processing parameters and sterility validation records.

Source traceability — full chain of custody from animal origin to finished device.
Biocompatibility validation — ISO 10993-series testing including cytotoxicity and irritation evaluation.
Sterility validation — terminal sterilization process validated to recognized standards.
Lot release testing — every production lot subjected to release criteria prior to distribution.
Clinical-grade biological substrate — processed to preserve regenerative architecture suitable for guided Bone or soft-tissue regeneration.
Product description last updated: May 19, 2026

Related Products